Billings Clinic
Especially For:

Clinical Trials

Title   Head and Neck (RTOG 1016): HPV Associated Oropharynx Cancer
Description   A Randomized Phase III Trial of Radiotherapy Plus Cetuximab versus chemotherapy in HPV-Associated Oropharynx Cancer.
IRB Number   RTOG R1016
Category   Head and Neck
Inclusion/Notes   Must be positive for p16 as determined by central lab prior to study entry. Clinical stage T1-2 N2a-N3 or T3-4 any N w/ no distant metastasis. Ineligible if gross total excision of both primary and nodal disease is performed. Cancers from the oral cavity site are not eligible. Carcinoma of the neck of unknown primary site origin are not eligible.
Status   Active
Start Date   08/12/2011
Principal Investigator (PI)   John Schallenkamp, MD
Contact Name   Susan Dillon, Rn
Contact Email
Phone   (406) 435-7443
Fax   (406) 435-7489
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.